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Abstract:  
 
Background: Pressure injuries are localised areas of injury to the skin and/or underlying tissues. 
Objectives: To assess foam dressings compared to other dressings in healing pressure injuries. 
Design: Systematic review and meta-analysis Data sources: The review team searched: the Cochrane 
Wounds Specialised Register; the Cochrane Central Register of Controlled Trials; Ovid MEDLINE; Ovid 
Embase; EBSCO CINAHL Plus and the NHS Economic Evaluation Database. Authors also searched 
clinical trials registries and scanned reference lists for reviews, meta-analyses and health technology 
reports. No restrictions were applied to language, publication date or study setting.Study eligibility 
AC
CE
PT
ED
 M
AN
US
CR
IPT
   2 
 
criteria: Published or unpublished randomised controlled trials and cluster- randomised controlled 
trials that examined the clinical or cost effectiveness of foam dressings for healing pressure injuries. 
Participants: Patients of any age with a pressure injury of Stage II or above in any care setting. 
Interventions: Use of any foam wound dressing for treating Stage II pressure injuries or above. Study 
appraisal and synthesis methods: Full-text were assessed for eligibility using a priori criteria by two 
authors. Risk of bias was assessed using the Grading of Recommendations, Assessment, 
Development and Evaluation criteria, and Consolidated Health Economic Evaluation Reporting 
Standards. Risk ratio and mean difference with 95% confidence intervals were used to measure the 
effect. The review team used Review Manager 5 to enter narrative and qualitative data of included 
studies. Results: Authors found nine studies published between 1994 and 2016 involving 483 
participants with pressure injuries at Stage II or above. Included studies compared foam dressings 
with other types of dressings. However, it was unclear if the foam dressing affected healing (RR 1.00, 
95% CI 0.78 to 1.28), time to complete healing (MD 5.67 days 95% CI-4.03 to 15.37), adverse events 
(RR 0.33, 95% CI 0.01 to 7.65), or reduction in pressure injury size (MD 0.30 cm2 per day, 95% CI -
0.15 to 0.75), as the certainty of the evidence was very low. Limitations: Using the Grading of 
Recommendations, Assessment, Development and Evaluation criteria, the certainty and 
completeness of evidence was low to very low, making it difficult to draw comparisons between 
foam and other dressings. Conclusions and implications: It is uncertain whether foam dressings are 
more clinically effective, more acceptable to users, or more cost effective compared to alternative 
dressings in treating pressure injuries. 
 
Keywords:  
 
Cost-effectiveness, foam dressings, meta-analysis, pressure injury, pressure ulcer, 
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Introduction 
Background 
Pressure injuries also known as pressure ulcers, are a localised injury to the skin, underlying 
tissue, or both. Pressure injuries usually occur over a bony prominence, such as the sacrum 
(base of the spine), heel, elbow, hip - including the ischium, shoulder, spinous processes on 
vertebrae, ankle, toe, head or face (Lahmann, Halfens, & Dassen, 2006; Shanin, Dassen, & 
Halfens, 2008; Vanderwee, Clark, Dealey, Gunningberg, & Defloor, 2007). Pressure injuries 
result from unrelieved pressure, or pressure in combination with opposing forces - where 
body weight is pushing in one direction, and another part of the body, usually skin, in the 
opposite direction - or as a result of medical devices (National Pressure Ulcer Advisory 
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Panel, European Pressure Ulcer Advisory Panel and, & Pan Pacific Pressure Injury Alliance, 
2016).  Irreversible tissue damage may occur in vulnerable people after as little as 30 minutes 
of uninterrupted pressure (Kirman & Geibel, 2016).   
 
Pressure injuries are an internationally recognised patient safety problem, estimated to affect 
2.5 million people annually (House, Giles, & Whitcomb, 2011). The prevalence of pressure 
injuries depends on patient factors and treatment settings (Vanderwee et al., 2007; VanGilder, 
Amlung, Harrison, & Meyer, 2009). A multisite study undertaken in European acute care 
settings found a prevalence of 10.5% to 18.1% with individual countries reporting prevalence 
rates between 8.3% and 23% (Vanderwee et al., 2007). A survey in the United States (US) 
estimated pressure injury prevalence of up to 13% in acute care settings and 29% to 32% in 
longer term acute care settings (VanGilder et al., 2009). Notably, this survey excluded Stage I 
pressure injuries from prevalence calculations due to the substantial inaccuracies in their 
assessment (VanGilder et al., 2009). In Australia, pressure injury point prevalence studies 
conducted in Victoria across 136 metropolitan and rural health service sites between 2003 
and 2006 showed a decrease in the prevalence of people with pressure injuries (stages I to IV) 
from 26.5% to 17.6%. However, the proportion of people with pressure injuries acquired in 
hospital remained unchanged (67.6% in 2003 versus 67.7% in 2006 (Quality Safety Branch., 
2017).  
 
Internationally, there has been substantial investment over recent decades in monitoring, 
preventing and treating pressure injury to reduce their incidence and associated costs. 
Consequently, there is increasing evidence of the economic burden of pressure injuries. 
Graves & Zheng (2014) estimated the direct health cost of pressure injuries in hospital and 
residential care settings in Australia for 2010-11 to be USD 1.65 billion (~Euro 1.42billion; 
USD1 ~ Euro0.86 ~ AUD1.34 ~ GBP0.75 at June 2018). Nguyen, Chaboyer, and Whitty 
(2015) estimated an annual treatment cost of AUD 983 million representing 1.9% of all 
public hospital expenditure, and an additional opportunity cost of AUD 819 million 
associated with 524,661 bed days lost, giving an overall cost of pressure injuries of AUD 1.8 
billion (~USD 1.3 billion, Euro 1.2 billion) per annum. Dealey and colleagues (2012) 
estimated the approximate total cost of pressure injuries in the United Kingdom (UK) in 2011 
as GBP 3.36 billion (~USD $4.5 billion, Euro 3.8 billion) with an expected average cost of 
healing a Stage III or IV pressure injury of between GBP 9000 and GBP 14,000. In the USA, 
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total costs for pressure injury treatment were estimated at USD 9.1 to USD 11.6 billion (~ 
Euro 7.8 to 9.8 billion) in 2014 (U. S. Agency for Healthcare Research Quality, 2016).  
 
Rationale 
Pressure injuries are an internationally recognised patient safety problem and serve as a 
clinical indicator for the standard of care provided. As a result, there has been significant 
investment in strategies aimed at pressure injury prevention. However, pressure injuries 
remain prevalent in many care settings. Dressings are widely used to treat pressure injury and 
understanding the existing evidence base and questions around clinical and cost-effectiveness 
of different dressing types is important for effective decision making. 
Objectives 
The clinical question assessed by the review team focussed on: patients of any age and in any 
care setting; with a Stage II (or above) pressure injury; treated with any type of foam dressing 
to heal or reduce their injury in any time period. Hence the objectives of this review were to 
assess the clinical and cost effectiveness of foam wound dressings for healing pressure 
injuries in people with existing pressure injuries in any care setting.   
 
Methods 
Protocol and registration 
The Cochrane Review on which this abridged version is based was published in 2017 
(Walker, Gillespie, Thalib, Higgins, & Whitty, 2017) 
Types of studies 
The review team included all randomised controlled trials (RCTs) and cluster-RCTs 
irrespective of publication status or language. Review authors excluded non-randomised, 
clinical controlled trials and cross-over trials. The critical review of health economic 
evidence included, where possible, comparative full and partial economic evaluations 
conducted within the framework of eligible studies (that is., cost-effectiveness analyses, cost-
utility analyses, cost-benefit analyses and cost analyses that included a dressing intervention 
and a relevant comparator), as well as eligible studies reporting more limited information, 
such as estimates of resource use or costs associated with dressings and a comparator. 
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Review authors only considered health economics studies conducted alongside clinical 
effectiveness studies that were included in this review. 
Types of participants 
The review authors included studies that recruited people of any age with a diagnosis of 
pressure injury of Stage II or above in any care setting using the National Pressure Ulcer 
Advisory Panel, European Pressure Ulcer Advisory Panel, and Pan Pacific Pressure Injury 
Alliance International Pressure Ulcer Classification System Criteria (2016). The team also 
used alternative pressure injury classification systems, such as the Stirling (Reid & Morison, 
1994), and Torrance classification systems (Harker, 2000), as well as earlier versions 
published by the National Pressure Ulcer Advisory Panel (1989), based on close alignment to 
contemporary National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory 
Panel and, & Pan Pacific Pressure Injury Alliance criteria (2016).  Review authors excluded 
studies involving participants with Stage I pressure injury because although ’at-risk’ signs 
and symptoms of potential pressure injury such as non-blanchable redness, pain, hardness or 
softness, heat or coolness are present, the skin remains intact and therefore is unlikely to 
require a dressing (National Pressure Ulcer Advisory Panel, European Pressure Ulcer 
Advisory Panel and, & Pan Pacific Pressure Injury Alliance, 2016). 
Types of interventions 
The primary intervention under investigation was the use of any foam wound dressing for 
treating Stage II pressure injuries or above. The review team included any trial in which the 
presence or absence of a foam dressing was the only systematic difference between treatment 
groups, and anticipated that comparisons would include: 
 different types of foam dressings compared with each other; 
 foam dressings compared with other dressings or active treatments, or both, and; 
 foam dressings compared with no dressing treatment. 
Review authors presented data for short-term (8 weeks or less) and medium follow-up (up to 
24 weeks). 
 Primary outcomes for the review were:  
 Incidence of healed pressure injuries (proportion of participants in whom a pressure 
injury healed); 
 Time to complete healing; 
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 Adverse events (such as wound and/or systematic infection). 
Secondary outcomes included reduction in pressure injury size, quality of life, patient 
satisfaction/acceptability, pressure injury recurrence (Stage II or above), or pain associated 
with a pressure injury and/or dressing removal. The review team considered pressure injury 
associated cost, utility scores representing health-related quality of life, incremental cost per 
event, or net health or monetary benefit, as economic outcomes. 
Information sources and search strategy 
The search strategy was guided by the Cochrane Wounds Review Group and used  electronic 
databases and specialised registers to identify reports of relevant clinical trials and economic 
studies up to February 2017 including: the Cochrane Wounds Specialised Register; the 
Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 1) in the Cochrane 
Library; Ovid MEDLINE including In-Process & Other Non- Indexed Citations Ovid 
Embase; EBSCO CINAHL Plus, and; the NHS Economic Evaluation Database (NHS EED) 
in the Cochrane Library. 
Review authors also searched the following clinical trials registries up to March 2017: 
ClinicalTrials.gov; World Health Organization (WHO) International and Clinical Trials 
Registry Platform and scanned reference lists of relevant included studies as well as reviews, 
meta-analyses and health technology reports to identify additional studies. There were no 
restrictions with respect to language, date of publication or study setting. The complete 
search strategy is detailed in Supplementary file 1. 
Study selection  
Two review authors independently assessed titles and abstracts of all citations retrieved by 
the search for relevance against the inclusion criteria. The review team retrieved full-text 
versions of potentially eligible studies and independently assessed the full papers for 
eligibility, with disagreements resolved through input by a third author (Higgins & Deeks, 
2011). When the eligibility of a study was unclear, review authors attempted to contact study 
authors.  
Data collection process and extraction 
Two authors independently extracted and summarised data from eligible studies and cross-
checked for accuracy and agreement. Data extraction included a comprehensive range of 
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variables that included study design integrity as well as economic estimates and specific 
items of interest. In cases where data were not clear or reported, review authors assumed that 
missing data were due to loss of follow-up (missing at random) and analysed the available 
information.  
Risk of bias in individual studies 
The review team linked Cochrane risk of bias ratings to the Grading of Recommendations, 
Assessment, Development and Evaluation assessment using an adaptation by Guyatt and 
colleagues (2011), to define the four risk of bias ratings from very high risk of bias to low 
risk of bias with an unclear option due to insufficient information (Westby, Dumville, Soares, 
Stubbs, & Norman, 2017). 
 Grading of Recommendations, Assessment, Development and Evaluation ratings started at 
’high’ as only RCTs and cluster-RCTs were included in this review. The review team 
downgraded studies according to five factors: 1) limitations in the design and implementation 
suggesting the high likelihood of bias; 2) indirectness of evidence (population, intervention, 
control, outcomes); 3) unexplained heterogeneity or inconsistency of results; 4) imprecision 
of results; 5) high probability of bias (Schünemann et al., 2011).  
Summary measures 
For measures of treatment effect, review authors calculated risk ratio (RR) with 95% 
confidence intervals (CI) for dichotomous outcomes and mean difference (MD) with 95% CIs 
for trials with continuous outcomes that used the same assessment scale. When trials used 
different assessment scales, review authors planned to use the standardised mean difference 
(SMD) with 95% CIs. Review authors planned to report time-to-event data (e.g. time-to-
healing) as hazard ratio (HR) when possible (Deeks, Higgins, & Altman, 2011).  
The review team presented a narrative description of the economic data.  
Syntheses of results  
The review authors analysed quantitative data using RevMan 5 (Nordic Cochrane Centre, 
2014). For dichotomous outcomes, review authors calculated RR plus 95% CI and explored 
the robustness of meta-analyses using appropriate meta-analytical models based on the level 
of heterogeneity (Deeks et al., 2011). 
Results of individual studies 
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The nine trials included 483 participants. The trials were small, and based on their reported 
data review authors calculated a median sample size of 29 and inter-quartile range (IQR) of 
24. Although there was clinical and methodological heterogeneity, review authors undertook 
meta-analysis where there was similarity between dressings, follow-up periods and stages of 
pressure injury subgroups. Where there was no similarity, review authors summarised studies 
narratively. 
 
Results 
Study selection 
The search generated 1,352 records. In total, the review team excluded 1,326 studies and 
assessed 26 as full text articles for eligibility. Refer to Figure 1 (Moher, 2009).  
 
Figure 1 here  
             
 
Study characteristics 
Nine randomised controlled trials with a total of 483 participants met the inclusion criteria for 
this review but only eight were suitable for meta-analyses (Bale et al., 1997; Banks & 
Harding, 1994a; Meaume et al., 2003; Payne et al., 2009; Seeley, Jensen, & Hutcherson, 
1999; Sopata, Lucak, & Ciupinska, 2002; Souliotis, Kalemikerakis, Saridi, Papageorgiou, & 
Kalokerinou, 2016; Thomas et al., 1997). The study by Bale and colleagues (1998), was not 
included in the meta-analyses as it used multiple subgroup analyses for which results may 
have been misleading. Supplementary file 2 outlines the methodology, participants and 
interventions of the included trials.  
Health settings comprised community, aged and palliative-care facilities. Six included studies 
used an intention-to-treat approach (Polit & Gillespie, 2010), where there was limited or no 
participant loss following randomisation (Bale et al., 1998; Meaume et al., 2003; Payne et al., 
2009; Seeley et al., 1999; Sopata et al., 2002; Thomas et al., 1997). The remaining studies 
(Banks & Harding, 1994a; Souliotis et al., 2016), used a per-protocol approach.  
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Participants were recruited from the UK (Bale et al., 1998; Banks & Harding, 1994a; Thomas 
et al., 1997), Greece (Souliotis et al., 2016), Belgium, France and Italy (Meaume et al., 2003); 
a Poland (Sopata et al., 2002), and the US (Payne et al., 2009; Seeley et al., 1999). Five 
centres referred to in Bale et al. (1997) were not specified although presumably they were in 
the UK.  
Participants’ mean age in eight trials was ≥ 73 years (Bale et al., 1998; Bale et al., 1997; 
Banks & Harding, 1994a; Meaume et al., 2003; Payne et al., 2009; Seeley et al., 1999; 
Souliotis et al., 2016; Thomas et al., 1997). The study by Sopata and colleagues (2002) was 
the exception with a mean aged of 59 years. The most predominant pressure injury site was 
the sacrum (Bale et al., 1997; Banks & Harding, 1994a; Meaume et al., 2003; Payne et al., 
2009; Seeley et al., 1999; Souliotis et al., 2016; Thomas et al., 1997).  
In the included studies, foam dressings consisted of hydrocellular foam (Bale et al., 1998; 
Seeley et al., 1999); hydropolymer foam (Meaume et al., 2003; Thomas et al., 1997); 
polyurethane foam (Bale et al., 1997; Banks & Harding, 1994a; Payne et al., 2009; Sopata et 
al., 2002); silicone foam (Meaume et al., 2003); as well as foam dressings with antimicrobial 
(silver and silver-sulfadiazine), and analgesic (ibuprofen) properties (Souliotis et al., 2016). 
Where possible, review authors considered foam dressings as a single group. Four studies 
compared a foam dressing with a hydrocolloid dressing (Bale et al., 1998; Bale et al., 1997; 
Seeley et al., 1999; Thomas et al., 1997), three compared foam dressing(s) with basic wound 
contact dressings (Banks & Harding, 1994a; Payne et al., 2009; Souliotis et al., 2016), one 
compared a foam dressing with a hydrogel dressing (Sopata et al., 2002) and one study 
compared two different types of foam dressing (Meaume et al., 2003).  Table 1 summarises 
the outcomes reported in included trials. 
Table 1 here 
The primary outcome, incidence of healed pressure injuries was the most frequently reported 
followed by adverse events, and time to complete healing. For secondary outcomes, five trials 
reported reduction in pressure injury size, two reported patient satisfaction and pain. None of 
the included studies reported outcomes for quality of life or pressure injury recurrence. 
Economic outcomes were reported in three trials. 
 
Risk of bias within studies 
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Eight of the nine included studies were at high risk of bias for one or more domains (Figure 
2). Overall, the quality of reporting was limited due to lack of clarity and detail. Five trials 
were assessed as having a high risk of bias for blinding of personnel, and seven trials as being 
high risk of bias for blinding of outcome assessment. Some studies had unclear or high risk of 
attrition bias due to their per-protocol approach, or reported incomplete outcome data with 
insufficient descriptions for follow-up and comparator data. 
 
Figure 2 here 
 
Synthesis of results  
Included studies were synthesised according to outcome measures and assessed for risk of 
bias according to the dressings being compared. 
Comparison 1: hydropolymer foam dressing compared with silicone foam dressing 
(short-term follow-up,8 weeks or less) 
This comparison included one trial with 38 participants (Meaume et al., 2003). It compared a 
foam dressing (hydropolymer foam) with another foam dressing (silicone foam). For primary 
outcome incidence of healed pressure injuries, it was unclear if alternative types of foam 
dressings affected the incidence of healed pressure injuries over a short-term follow-up 
period: RR 0.89 (95% CI 0.45 to 1.75). It was also unclear if the alternative foam dressings 
affected the risk of primary outcome adverse events in people with pressure injuries: RR 0.37 
(95% CI 0.04 to 3.25). The certainty of evidence was very low due to high risk of bias (lack 
of blinding) and serious imprecision of results due to low number of events and wide 
confidence intervals. Meaume and colleagues (2003) did not report primary outcome: time to 
complete healing. 
For secondary outcomes, reduction in pressure injury size was measured in cm2 from tracings 
of each participant's wound at baseline and final assessment (Meaume et al., 2003). Wounds 
dressed with the silicone foam dressing had a mean reduction in wound area of 3.1 cm2 
compared with 3.3 cm2 in the hydropolymer foam dressing. No standard deviation or standard 
error data were reported and so could not be analysed further. Evidence was limited due to 
lack of blinding, a small sample size and incomplete of reporting. Meaume and colleagues 
(2003) did not report any other secondary outcomes, or any economic outcomes. 
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Comparison 2: foam (hydrocellular, hydropolymer and polyurethane dressings 
compared with hydrocolloid dressings (short-term follow-up, 8 weeks or less) 
This comparison included four trials with 230 participants (Bale et al., 1998; Bale et al., 
1997; Seeley et al., 1999; Thomas et al., 1997).  
Only three trials reported incidence of healed pressure injuries (Bale et al., 1997; Seeley et 
al., 1999; Thomas et al., 1997). Follow-up times ranged from four weeks (Bale et al., 1997), 
six weeks (Thomas et al., 1997) and eight weeks (Seeley et al., 1999). It was unclear whether 
foam dressings affected the incidence of healed pressure injuries compared with hydrocolloid 
dressings over a short-term period: RR 0.85 (95% CI 0.54 to 1.34) (Refer Figure 3). None of 
the trials included in this comparison reported time to complete healing (Bale et al., 1997; 
Seeley et al., 1999; Thomas et al., 1997). Bale and colleagues (1998) did not report any 
primary outcomes. 
Figure 3 here 
Three studies reported dressing-related adverse events (Bale et al., 1997; Seeley et al., 1999; 
Thomas et al., 1997). Once again it was uncertain if foam dressings affected the risk of 
adverse events compared with hydrocolloid dressings RR 0.88 (95% CI 0.37 to 2.11) (Refer 
to Figure 4. The certainty of evidence was very low due to uncertain blinding and allocation 
concealment, small sample size, wide confidence intervals and incomplete reporting.  
Figure 4 here 
Bale et al., (1998) and Thomas et al., (1997) (n = 131) reported on secondary outcomes 
reduction in pressure injury size. However, data were not separated by wound type in both 
studies preventing further analysis. As such it was unclear if foam dressings led to reduction 
in pressure injury size compared to hydrocolloid dressings due to lack of blinding and 
allocation concealment, small sample size and incomplete reporting. Bale (1997) and Seeley 
(1999) did not report reduction in pressure injury size. 
Seeley (1999) used a 4-point rating scale (0 = none, 1 = mild, 2 = moderate, 3 = severe) to 
assess secondary outcome pain. It was uncertain if the foam dressing affected wound pain 
(mean 0.15, SD 0.8, n = 20) compared with the hydrocolloid dressing (MD -0.32, 95% CI -
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0.86 to 0.22). Thomas (1997) recorded pain and discomfort associated with the dressing 
(comfortable or otherwise and reported p= 0.023) however did not report any further details.  
Comparison 3: polyurethane foam dressing compared with hydrogel dressing (short-
term follow-up, 8 weeks or less) 
This trial included 34 participants and compared foam dressing with hydrogel dressing over a 
short-term follow-up (2002). It was uncertain whether treatment with a foam dressing affected 
the incidence of healed pressure injuries compared with a hydrogel dressing: RR 1.00 (95% 
CI 0.78 to 1.28). Time to complete healing was reported in days (mean ± SD). Compared to 
the hydrogel dressings, foam dressings were associated with an increased number of 
treatment days MD 5.67 days, (95% CI -4.03 to 15.37), although this increase was not 
statistically significant. One adverse event was reported in the hydrogel dressing group (1/17) 
where the Stage II pressure injury increased in size. It was unclear if foam dressings affected 
the incidence of adverse events compared with hydrogel dressings: RR 0.33 (95% CI 0.01 to 
7.65). The review team assessed the evidence as very low certainty due to lack of blinding, 
due small sample size and wide confidence intervals. 
Sopata and colleagues (2002) reported only one secondary outcome - reduction of pressure 
injury size - for healed pressure injuries only (n = 30). The mean difference was 0.30 cm2 per 
day (95% CI -0.15 to 0.75). It was unclear if foam or hydrogel dressings had any impact on 
the reduction of pressure injury size. While Sopata and colleagues (2002) compared wound-
healing rates with Banks & Harding (1994a), no supporting data were presented. Evidence 
was downgraded due to lack of blinding, small sample size, wide confidence intervals and 
incomplete reporting. 
Comparison 4: foam (polyurethane, silver and ibuprofen-releasing) foam dressings* 
compared with basic wound contact dressings (gauze, saline-soaked gauze, low-
adherence dressing secured by a vapour-permeable film) (short to medium-term follow-
up, 4 to 24 weeks) 
Three trials (Banks & Harding, 1994a; Payne et al., 2009; Souliotis et al., 2016) comprising 
181 participants compared foam dressings with basic wound contact dressings. Follow-up 
times ranged from short-term - 4 weeks - for Payne et al., (2009), medium term - 12 weeks - 
for Banks & Harding (1994a) and just over 17 weeks for Souliotis et al., (2016). 
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For short-term follow-up of primary outcomes, it was uncertain if there is a difference in the 
incidence of healed pressure injury for Payne and colleagues (2009) (n = 36) RR 1.33 (95% 
CI 0.62 to 2.88).  For medium-term follow-up of incidence of healed pressure injury, it was 
unclear if foam dressings impacted on the incidence of healed pressure injury compared with 
the control dressing which consisted of a layer of knitted viscous multifilament yarns in 
Banks & Harding (1994a) (n = 50) RR 1.17 (95% CI 0.79 to 1.72).  
Based on 95 patients, Souliotis and colleagues (2016) compared a foam dressing to basic 
dressing on time to complete wound healing. Based on their data, review authors estimated 
the foam dressings were significantly associated with a decreased time to complete healing 
with an average median time of 35.8 days (95% CI 14.8 to 56.8). Souliotis et al., (2016) 
reported 12 adverse events related to wound infections in the foam dressings group (n = 48), 
compared with 21 in the basic wound contact dressing group: RR 0.58 (95% CI 0.33 to 1.05). 
The review team assessed this as very low certainty evidence with a high risk of bias due to 
lack of blinding, small sample size, wide confidence intervals and incomplete reporting. 
Banks & Harding (1994a) and Payne et al., (2009) did not report time to complete healing or 
adverse events. 
For secondary outcome reduction in pressure injury size, Payne et al., (2009) (n = 36) 
documented the size of participants' pressure injuries, but did not report the final assessment 
of wound size to enable comparison. Banks & Harding (1994a) and Souliotis et al., (2016) 
did not report reduction in pressure injury size. Banks & Harding (1994a) reported mean 
scores, for secondary outcome patient satisfaction/acceptability but did not provide any other 
information, such as standard deviation or variance data, from which review authors could 
make a meaningful interpretation. Payne (2009), Souliotis (2016) and colleagues did not 
report patient satisfaction / acceptability. 
Banks & Harding (1994a) also used a patient acceptability questionnaire to record pain on 
dressing removal using a scale from 0 = painful to 10 = painless, but did not provide any 
other information, which review authors could make a meaningful interpretation. Payne et al., 
(2009), Souliotis et al., (2016) and Thomas et al., (1997) did not report pain, and none of the 
studies included in this comparison reported quality of life. 
Economic outcomes 
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For economic outcomes, Bale (1998) compared material costs (of dressings and saline) for 
the participant subgroups using foam and hydrocolloid dressings. Costs were reported as 
GBP using a 1994-cost year. The total cost of treatment was GBP 844 (mean GBP 50 per 
participant, n = 17) for using the foam dressing compared to GBP 1142 (mean GBP 76 per 
participant, n = 15) for the hydrocolloid dressing (statistical significance of the difference not 
reported). The study authors did not draw conclusions regarding the cost-effectiveness of 
foam dressings for the management of PI. The Consolidated Health Economic Evaluation 
Reporting Standards checklist assessment indicated methods were inconsistently described or 
absent, and reporting of results incomplete.   
Both Payne (2009), Souliotis (2016) and colleagues’ reported the economic outcomes cost 
and incremental cost per event. Payne et al., (2009) (n = 36) analysed treatment costs 
(dressings, other materials, and nurse time) until pressure injury healing or 28 days, 
whichever occurred first. They reported costs as USD using a cost year of 2006/7. The 
polyurethane foam dressing was less costly per participant (USD 315) than saline-soaked 
gauze (USD 781), representing a mean saving of USD 466 per participant in the foam group 
(P = 0.055). The study authors reported the foam dressing to be dominant; that is, less costly 
and more effective in terms of number of participants healed by 28 days and pressure injury-
free days per participant. They concluded that the foam dressing was cost-effective compared 
to saline-soaked gauze for the treatment of Stage II pressure injury. However, the study was 
not powered to detect differences in time to healing which was not observed to differ between 
groups at the 5% level.  
Souliotis and colleagues (2016) reported total and per-participant treatment costs (including 
dressings, labour and materials) in the home setting until healing (medium-term follow-up, 8 
to 24 weeks). The cost year was not stated. Treatment costs over the study period (to pressure 
injury healing) indicated foam dressings were less costly overall (EUR 63,543 for 47 
participants) and per participant (EUR 1351) than plain gauze overall (EUR 186,638 for 48 
participants) or per participant (EUR 3888). However, they did not report the statistical 
significance of this difference. Therefore, although the study authors also reported a shorter 
average healing time for the foam dressing than the gauze dressing group, it is not possible to 
draw strong conclusions around cost effectiveness. 
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For both Payne (2009) and Souliotis (2016), a lack of data prevented further analysis and 
review authors are uncertain about the relative impact of foam dressings on economic 
outcomes compared with basic wound contact dressings. 
Banks & Harding (1994a) did not report economic outcomes. 
Discussion 
Summary of evidence 
This review of nine trials with 483 participants includes all the currently available RCT 
evidence evaluating foam dressings to treat pressure injuries (stage II or above). The review 
team also sought economic outcomes, such as cost, utility scores and incremental costs. 
Overall, the certainty of the evidence was poor. The review team judged Grading of 
Recommendations, Assessment, Development and Evaluation assessments as being of low to 
very low certainty for all included trials, due to serious risk of bias related to lack of blinding 
and allocation concealment, and imprecision due to small samples or lack of data, or both. 
Most evidence for all included trials was at high risk of bias due to limitations in design and 
implementation (related to lack of blinding or allocation concealment, or both) and serious 
imprecision of results (related to all or a combination of small sample size, wide confidence 
intervals and lack of reporting). Therefore, review authors are unable to draw reliable 
conclusions about clinical advantages, cost-effectiveness or patient satisfaction/acceptability 
between the different types of foam dressings or foam dressing compared with other 
dressings. 
More specifically, review authors found uncertain evidence about whether foam dressings 
presented any substantial clinical advantages when compared with other dressings in terms of 
impact on incidence of pressure injury, increasing the time to healing of pressure injuries, 
preventing adverse events associated with pressure injuries, or reducing the size of pressure 
injury. There was also limited available evidence to base conclusions about the comparative 
impacts of foam dressings for pressure injuries on quality of life, pain, and satisfaction and 
acceptability for participants. Evidence that would have benefitted decision makers such as 
rigorous cost evaluations and longer-term cost-effectiveness evaluations and quality of life 
outcomes was incomplete or absent. 
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There was an overlap of investigators in the teams of four trials (Bale et al., 1998; Bale et al., 
1997; Banks & Harding, 1994a; Thomas et al., 1997). These trials are dated by 20 or more 
years; hence, review authors were unable to contact the study authors with requests for 
additional information. Where review authors were able to contact study authors, they no 
longer had access to data or could not recall details of individual trials (Bale et al., 1998; Bale 
et al., 1997; Banks & Harding, 1994a; Sopata et al., 2002; Thomas et al., 1997). Apart from 
an included trial published in 2016, the date of publication for the remaining eight trials 
(1994 to 2009), may also explain the absence of a standardised approach - such as the 
Consolidated Standards of Reporting Trials statement (Schulz, Altman, Moher, & Consort 
Group, 2010) - to report methods and results. Consequently, there was a high degree of 
variability between studies in terms of dressings used, follow-up periods, interventions and 
outcomes.  
There was methodological diversity due to: selection bias related to the generation of 
randomisation sequences (Bale et al., 1998; Payne et al., 2009; Sopata et al., 2002; Souliotis 
et al., 2016; Thomas et al., 1997); allocation concealment (Bale et al., 1998; Bale et al., 1997; 
Payne et al., 2009; Sopata et al., 2002; Souliotis et al., 2016); lack of blinding of participants 
and personnel (Meaume et al., 2003; Payne et al., 2009; Seeley et al., 1999; Sopata et al., 
2002; Souliotis et al., 2016); outcome assessment (Bale et al., 1998; Meaume et al., 2003; 
Payne et al., 2009; Seeley et al., 1999; Souliotis et al., 2016; Thomas et al., 1997); and 
attrition bias (Bale et al., 1997). While the review team acknowledge that it is difficult to 
blind participants and personnel in studies where there is physical evidence of treatment 
allocation, none of the eight included studies demonstrated blind-to-intervention assessment. 
Other sources of bias included industry sponsorship, disclosed in three of the nine included 
trials (Bale et al., 1998; Bale et al., 1997; Payne et al., 2009).  
Limitations 
The review considered the evidence that it was possible to obtain and included studies that 
were not published in English-language journals. It is possible that there may be unpublished 
data that review authors have not been able to access, as well a potential for publication bias; 
however, this is very unlikely given the range of findings from this review. There were 
deviations from the protocol related to alternative pressure injury classification systems, 
namely the Stirling (Reid & Morison, 1994) and Torrance classification systems (Harker, 
2000), and earlier versions published by the National Pressure Ulcer Advisory Panel  
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(NPUAP, 1989) that deviated from the contemporary International National Pressure Ulcer 
Advisory Panel, European Pressure Ulcer Advisory Panel and, & Pan Pacific Pressure Injury 
Alliance Pressure Ulcer Classification System Criteria (2016). The review team accepted 
these alternative classification systems on the condition that the definitions of stage/grade 
closely matched the contemporary International National Pressure Ulcer Advisory Panel, 
European Pressure Ulcer Advisory Panel and, & Pan Pacific Pressure Injury Alliance 
Pressure Ulcer Classification System Criteria. Review authors also included studies that 
recruited participants with Stage II pressure injuries or above alongside patients with other 
types of chronic wounds, such as venous and arterial leg ulcers or diabetic foot ulcers, if the 
results for people with relevant pressure injuries were presented separately (or this data were 
available from study authors). Similarly, when a study included both Stage I and more 
advanced pressure injuries, review authors included it in the review only if data for Stage II 
and above were reported separately, or if the data were available on request from study 
authors. Review authors also included studies where pressure injuries from Stage II and 
above were reported collectively. It was not possible to evaluate the wider possibility of 
publication bias as there was variability of reporting between the included studies, and there 
were challenges in contacting or sourcing additional information from authors due to age of 
the studies. Because of this heterogeneity, review authors were only able to combine studies 
for comparison based on their shared outcomes. 
Conclusions and implications for nursing 
This comprehensive review of current evidence found no conclusive indication of differential 
effects of foam dressings compared with alternative wound treatments on the outcomes that 
matter for pressure injuries (including healing), or cost-effectiveness. The review team 
assessed all included  trials (Bale et al., 1998; Bale et al., 1997; Banks & Harding, 1994a; 
Meaume et al., 2003; Payne et al., 2009; Seeley et al., 1999; Sopata et al., 2002; Souliotis et 
al., 2016; Thomas et al., 1997) as having low- to very low-quality evidence due to risk of bias 
stemming from unblinded outcome assessment, and occasional selective reporting; 
inconsistent reporting and; imprecision of results from small and underpowered trials, with 
relatively short follow-up times (mean 8 weeks). 
There is a compelling need to evaluate the clinical and cost-effectiveness of foam dressings to 
treat pressure injuries. Currently there is no evidence of a difference in healing between 
pressure injuries dressed with foam dressings and those treated with the other dressings that 
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have been evaluated. In terms of dressing choice, any investment in future research must 
maximise its value in terms of clinical and cost-effectiveness to decision makers. Given the 
large number of dressing options, the design of future trials should be driven by high priority 
questions from patients and other decision makers. It is also important for researchers to 
ensure that the outcomes that are collected in research studies are those that matter to 
patients, carers and health professionals and that the follow-up times for trials are long 
enough to capture these. Where trials are conducted, good practice guidelines must be 
followed for their design, implementation and reporting. Further reviews are being conducted 
to synthesise evidence regarding the effect of other dressings on the treatment of pressure 
injuries. It would be useful to conduct further evidence synthesis (overviews of reviews, 
network meta-analyses or both) to aid decision making about the choice of dressings for 
pressure injuries across all dressing options. 
What is already known about the topic? 
 Pressure injuries can occur in people of all ages in all health settings. 
 Pressure injuries are often painful, complex and costly to treat for health providers. 
 There is a plethora of dressings available on the market, although little evidence about 
their effectiveness in treating pressure injuries. 
What this paper adds 
 Findings show certainty of evidence from reviewed studies is low to very low, with 
high risk of bias due to lack of blinding, small sample sizes and incomplete reporting. 
 There is no clear evidence that foam dressings are any better or worse than other 
dressings for treating pressure injuries. 
 There is a compelling need for high-quality clinical trials to evaluate their clinical and 
cost effectiveness. 
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Figure Captions 
Records screened 
(n = 1,352) 
 Records excluded (n = 1323) 
 Was not a RCT or cluster-RCT 
 Did not compare foam dressings to other foam dressings, 
other dressing or active treatment of both, or routine care 
alone 
 Stage II pressure injury or above were not included 
 Patient was not the unit of analysis  
   
Articles excluded with reasons (n =16) 
 Classification system not specifically stated x 4 
 Not a RCT or cluster-RCT x 3 
 Patient not the unit analysis x 3 
 Results did not include sub-group analysis for patients with 
pressure injury x 2 
 Patients with pressure injury not included in the study 
examining wounds x 2 
 Incomplete paper, that is; no outcome measures reported x 
1 
Study protocol x 1Trial added to ongoing studies (n = 1) 
Articles assessed 
for eligibility  
(n = 26) 
 
  
 
Trials included in 
qualitative 
synthesis (n = 9) 
 
  
Trials included in 
quantitative 
synthesis (meta-
analysis)  
(n = 8) 
 
 
Figure 1: Study flow diagram  
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*+ = low risk of bias, - = high risk of bias, ? = unclear risk of bias 
 
Figure 2: Risk of bias summary for included studies using GRADE* 
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Figure 3: Incidence of healing, short-term follow-up 
 
 
 
 
 
 
 
 
 
 
Figure 4: Adverse events, short-term follow-up 
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Table 1 : Summary of outcomes 
 Number of 
participant
s included 
in 
quantitativ
e analysis 
Follow-up 
periods 
Studies reporting 
quantitative 
outcomes 
Studies 
reporting 
qualitative 
outcomes 
Primary outcome(s)     
 Incidence of healed PI 170 Short term  
(8 weeks or 
less)  
 
Bale et al., 1997; 
Meaume et al., 2003; 
Payne et al., 2009; 
Seeley et al., 1999; 
Sopata et al., 2002*; 
Thomas et al., 1997 
 
24 Medium 
term (8 to 
24 weeks) 
Banks & Harding 
1994a 
 
 Time to complete healing 17 Short term  
 
Sopata et al., 2002;  
 
 
48 Medium 
term 
Souliotis et al., 2016  
 Adverse events 154 Short term  Bale et al., 1997; 
Meaume et al., 2003; 
Seeley et al., 1999; 
Sopata et al., 2002; 
Thomas et al., 1997 
  
48 Medium 
term 
Souliotis et al., 2016  
Secondary outcomes     
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 Reduction in ulcer size 15 Short term  Bale et al., 
1988; 
Meaume et 
al., 2003; 
Payne et al., 
2009; Sopata 
et al., 2002; 
Thomas et 
al., 1997 
 Quality of life (using any 
validated tool) 
Not reported 
 Patient 
satisfaction/acceptability 
(using any validated tool) 
 Short term  Bale et al., 
1998; 
 Medium 
term 
 Banks & 
Harding 
1994a 
 PI recurrence (Stage II or 
above) 
Not reported 
 Pain associated with PI or 
dressing removal (using 
any validated tool) 
 Short term  Seeley et al., 
1999; 
Thomas et 
al., 1997 
 Medium 
term 
 Banks & 
Harding 
1994a; 
Economic outcomes     
 PI associated costs,  utility 
scores representing 
health-related quality of 
life, incremental cost per 
event 
 Short term  Bale et al., 
1998; Payne 
et al., 2009  
 Medium term 
 
 Souliotis et 
al., 2016 
* In Sopata et al., (2002) one participant in the foam dressing group had two PI and one or more participants in 
the hydrogel dressing group had more than one wound. As we could not identify these patients in 
communication with the study author, we allocated one wound to each participant in the analysis.  
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